newsfilter
← Latest News
GlobeNewswire·

iTeos Therapeutics Announces $120 Million Registered Direct Offering

- Led by existing investors RA Capital Management and Boxer Capital- Purchase price of $17.50 represents a premium of approximately 44% to last close- Further strengthens balance sheet with pro forma cash position of